147 related articles for article (PubMed ID: 32974201)
41. Multiparametric MRI-based radiomics signature for preoperative estimation of tumor-stroma ratio in rectal cancer.
Cai C; Hu T; Gong J; Huang D; Liu F; Fu C; Tong T
Eur Radiol; 2021 May; 31(5):3326-3335. PubMed ID: 33180166
[TBL] [Abstract][Full Text] [Related]
42. Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound.
Liu Y; Shi S; Hua J; Xu J; Zhang B; Liu J; Yang XJ; Yu XJ
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):947-953. PubMed ID: 32144073
[TBL] [Abstract][Full Text] [Related]
43. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
[TBL] [Abstract][Full Text] [Related]
44. Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study.
Zhang H; Mao Y; Chen X; Wu G; Liu X; Zhang P; Bai Y; Lu P; Yao W; Wang Y; Yu J; Zhang G
Eur Radiol; 2019 Jul; 29(7):3358-3371. PubMed ID: 30963272
[TBL] [Abstract][Full Text] [Related]
45. The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis.
Li Z; Li X; Peng C; Dai W; Huang H; Li X; Xie C; Liang J
Front Oncol; 2020; 10():575272. PubMed ID: 33194685
[No Abstract] [Full Text] [Related]
46. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
47. Whole-tumor texture model based on diffusion kurtosis imaging for assessing cervical cancer: a preliminary study.
Zhang Q; Yu X; Ouyang H; Zhang J; Chen S; Xie L; Zhao X
Eur Radiol; 2021 Aug; 31(8):5576-5585. PubMed ID: 33464399
[TBL] [Abstract][Full Text] [Related]
48. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
[TBL] [Abstract][Full Text] [Related]
49. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
[TBL] [Abstract][Full Text] [Related]
50. Pathological assessment of chronic kidney disease with DWI: Is there an added value for diffusion kurtosis imaging?
Mao W; Ding Y; Ding X; Wang Y; Fu C; Zeng M; Zhou J
J Magn Reson Imaging; 2021 Aug; 54(2):508-517. PubMed ID: 33634937
[TBL] [Abstract][Full Text] [Related]
51. Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning Methods.
Han X; Yang J; Luo J; Chen P; Zhang Z; Alu A; Xiao Y; Ma X
Front Oncol; 2021; 11():606677. PubMed ID: 34367940
[TBL] [Abstract][Full Text] [Related]
52. Radiomics signature of brain metastasis: prediction of EGFR mutation status.
Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M
Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315
[TBL] [Abstract][Full Text] [Related]
53. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
54. Investigation of diffusion kurtosis imaging for discriminating tumors from inflammatory lesions after treatment for bladder cancer.
Wang F; Jin D; Hua XL; Zhao ZZ; Wu LM; Chen WB; Wu GY; Chen XX; Chen HG
J Magn Reson Imaging; 2018 Jul; 48(1):259-265. PubMed ID: 29232021
[TBL] [Abstract][Full Text] [Related]
55. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
[No Abstract] [Full Text] [Related]
56. A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors.
Liang W; Yang P; Huang R; Xu L; Wang J; Liu W; Zhang L; Wan D; Huang Q; Lu Y; Kuang Y; Niu T
Clin Cancer Res; 2019 Jan; 25(2):584-594. PubMed ID: 30397175
[TBL] [Abstract][Full Text] [Related]
57. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
[TBL] [Abstract][Full Text] [Related]
58. Utilization of radiomics to predict long-term outcome of magnetic resonance-guided focused ultrasound ablation therapy in adenomyosis.
Li Z; Zhang J; Song Y; Yin X; Chen A; Tang N; Prince MR; Yang G; Wang H
Eur Radiol; 2021 Jan; 31(1):392-402. PubMed ID: 32725335
[TBL] [Abstract][Full Text] [Related]
59. Prediction of High-Risk Cytogenetic Status in Multiple Myeloma Based on Magnetic Resonance Imaging: Utility of Radiomics and Comparison of Machine Learning Methods.
Liu J; Zeng P; Guo W; Wang C; Geng Y; Lang N; Yuan H
J Magn Reson Imaging; 2021 Oct; 54(4):1303-1311. PubMed ID: 33979466
[TBL] [Abstract][Full Text] [Related]
60. Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors.
Liu X; Wang T; Zhang G; Hua K; Jiang H; Duan S; Jin J; Zhang H
J Ovarian Res; 2022 Feb; 15(1):22. PubMed ID: 35115022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
